Imaging biomarkers of atherosclerosis

Biomarkers in Medicine

Volumn 2, Issue 6, 2008, Pages 555-565

  Noble, Stéphane ^a   Heinonen, Therese ^a   Tardif, Jean Claude ^a  

^a MONTREAL HEART INSTITUTE   (Canada)

Author keywords

Atherosclerosis imaging; Carotid intima media thickness; Computed tomography; Intravascular ultrasound; Molecular imaging; MRI; Optical coherence tomography; Quantitative coronary angiography; Vulnerable plaque

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GADOLINIUM; GLYCERYL TRINITRATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ANGIOCARDIOGRAPHY; ANGIOSCOPY; ANTIINFLAMMATORY ACTIVITY; ARTERIAL WALL THICKNESS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; CAROTID ARTERY; CLINICAL TRIAL; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED DIAGNOSIS; COMPUTER PROGRAM; CONTRAST ENHANCEMENT; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY OBSTRUCTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DISEASE MARKER; ELASTOGRAPHY; ELECTRON BEAM TOMOGRAPHY; HEALTH CARE COST; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; INTRAVASCULAR ULTRASOUND; MOLECULAR IMAGING; MULTIDETECTOR COMPUTED TOMOGRAPHY; NEAR INFRARED SPECTROSCOPY; NON INVASIVE MEASUREMENT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVER VARIATION; OPTICAL COHERENCE TOMOGRAPHY; PATIENT SAFETY; POSITRON EMISSION TOMOGRAPHY; PREDICTION; QUALITATIVE ANALYSIS; QUANTITATIVE DIAGNOSIS; RELIABILITY; REVIEW; THERMOGRAPHY; VIRTUAL REALITY;

EID: 59749092830     PISSN: 17520363     EISSN: None     Source Type: Journal    
DOI: 10.2217/17520363.2.6.555     Document Type: Review

References (94)

1. Yusuf S, Reddy S, Ounpuu S et al.: Global burden of cardiovascular diseases. I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation 104, 2746-2753 (2001).
2. McGill HC jr, McMahan CA, Herdcrick EE et al.: Effects of coronary heart disease risk factors on atherosclerosis of selected regions of the aorta and right coronary artery: PDAY research group, Pathobiological Determinants of Atherosclerosis in Youth. Arterioscler. Thromb. Vasc. Biol. 20, 836-845 (2000).
3. Virmani R, Burke AP, Farb A, Kolodgie FD: Pathology of the vulnerable plaque. J. Am. Coll. Cardiol. 47, C13-C18 (2006).
4. Greenland P, Abrams J, Aurigemma GP et al.: Prevention Conference. V. beyond secondary prevention, identifying the high-risk patient for primary prevention, noriinvasive tests of atherosclerotic burden, writing group III. Circulation 101, E16-E22 (2000).
5. Taylor AJ, Metz CN, Udelson JE: 34th Bethesda Conference: executive summary: can atherosclerosis imaging techniques improve the detection of patients at risk for ischemic heart disease? J. Am. Coll. Cardiol. 41, 1860-1862 (2003).
6. Chambless LE, Heiss G, Folsom AR et al.: Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk In Communities (ARIC) study, 1987-1993. Am. J. Epidemiol. 146, 483-494. (1997).
7. O'Leary DH, Polak J-F, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr: Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults: Cardiovascular Health Study Collaborative Research Group. N. Engl. J. Med. 340, 14-22 (1999).
8. Greenland P, LaBree L, Azen SP, Doherty TM, Detrano RC: Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. JAMA 291, 210-215 (2004).
9. Naghavi M, Libby P, Falk E et al.: assessment strategies: Part I from vulnerable plaque to vulnerable patient: a call for new definitions and risk. Circulation 108, 1664-1672 (2003).
10. Sones FM, Shirey EK, Proudfit WL, Wesrcott RN: Cine coronary arteriography (abstract). Circulation 20, 773 (1959).
11. Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Koletti GJ: Compensatory enlargement of human atherosclerotic coronary arteries. N. Engl. J. Med. 316, 1371-1375 (1987).
12. Little WC, Constantinescu M, Applegate RJ et al.: Can arteriography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease? Circulation 78, 1157-1166 (1988).
13. Arnett EN, Isner JM, Redwood CR et al.: Coronary artery narrowing in coronary heart disease: comparison of cineangiographic and necropsy findings. Ann. Intern. Med. 91, 350-356 (1979).
14. Grodin CM, Dyrda I, Pasternac A, Campeau L Bourassa MG: Discrepancies between cineangiographic and post-mortem findings in patients with coronary artery disease and recent myocardial revascularization. Circulation 49, 703-709 (1974).
15. Blankenhorn DH, Curry PJ: The accuracy of arteriography and ultrasound imaging for atherosclerosis measurement: a review. Arch. Pathol. Lab. Med. 106, 483-490 (1982).
16. Isner JM, Kishel J, Kent KM: Accuracy of angiographic determina tion of left main coronary arterial narrowing. Circulation 63, 1056-1061 (1981).
17. Roberts WC, Jones AA: Quantitation of coronary arterial narrowing at necropsy in sudden coronary death. Am. J. Cardiol. 44, 39-44 (1979).
18. Vlaodaver Z, French R, van Tassel RA, Edwards JE: Correlation of the antemortem coronary angiogram ajnd the postmortem specimen. Circulation 47, 162-168 (1973).
19. Zir LM, Miller SW, Dinsmore RE, Gilbert JP, Harthorne JW: Interobserver variability in coronary angiography. Circulation 53, 627-632 (1976).
20. Galbraith JE, Murphy ML, Desoyza N: Coronary angiogram interpretation: interobserver variability. JAMA 240, 2053-2059 (1981).
21. Topol EJ, Nissen SE: Our preoccupation with coronary luminology. The dissociation between clinical and angiographic findings in ischemic heart disease. Circulation 92, 2333-2342 (1995).
22. Brown BG, Bolson E, Frimer M, Dodge HT: Quantitative coronary arteriography: estimation of dimensions, hemodynamic resistance, and atheroma mass of coronary artery lesions using the arteriograms and digital computation. Circulation 55, 329-337 (1977).
23. Berry C, L'Allier PL, Grégoire J et al.: Comparison of intravascular ultrasound and quantitative coronary angiography for the assessment of coronary artery disease progression. Circulation 115, 1851-1857 (2007).
24. Tardif JC, Gregoire J, L'Allier PL et al.: Avasimibe and progression of lesions on ultrasound (A-plus) investigators. Effects of the acyl coenzyme A: cholesterol acyltransferase inhibitor avasimibe on human atherosclerotic lesions. Circulation 110, 3372-3377 (2004).
25. Jensen LO, Thayssen P, Pedersen KE, Stender S, Haghfelt T: Regression of coronary atherosclerosis by simvastatin: a serial intravascular ultrasound study. Circulaulation 110, 265-270 (2004).
26. Nissen SE, Tuzcu EM, Brewer HB, Sipahi I, Nicholls SJ, Ganz P: ACAT Intravascular Atherosclerosis Treatment Evaluation (ACTIVATE) investigators. Effect of ACAT inhibition on the progression of coronary atherosclerosis. N. Engl. J. Med. 354, 1253-1263 (2006).
27. Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. JAMA 290, 2292-2300 (2003).
28. Guédès A, Keller PF, L'Allier PL, Lespérance J, Grégoire J, Tardif JC: Long-term safety of intravascular ultrasound in nontransplant, nonintervened, atherosclerotic coronary arteries. J. Am. Coll. Cardiol. 45(4), 559-564 (2005).
29. Tardif JC, Gregoire J, L'Allier PL et al.: Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial. JAMA 297, 1675-1682 (4007).
30. Kimure BJ, Bhargava V, De Maria AN: Value and limitations of intravascular ultrasound imaging in characterizing coronary atherosclerotic plaque. Am. Heart J. 130, 386-396 (1995).
31. Maehara A, Mintz G, Bui A et al.: Morphologic and angiographic features of coronary plaque rupture detected by intravascular ultrasound. J. Am. Coll. Cardiol. 40 (5), 904-910 (2002).
32. Falk E, Shah PK, Fuster V: Coronary plaque disruption. Circulation 92, 657-671 (1995).
33. Lee RT, Libby P: The unstable atheroma. Arterioseler. Thromb. Vasc. Biol. 17, 1859-1867 (1997).
34. Virmani R, Kolodgie FD. Burke AR Farb A, Schwartz SM: Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 20, 1262-1275 (2000).
35. Moreno P, Sanz J, Fuster V: Atherothrombosis and high-risk plaque: definition, diagnosis and treatment. In: Topol Textbook of Interventional Cardiology (5th Edition). Saunders Elsevier, Amsterdam, The Netherlands. 1151-1168 (2008).
36. Waxman S, Ishibashi F. Muller J: Detection and treatment of vulnerablc plaques and vulnerable patients: novel approaches to prevention of coronary events. Circulation 114, 2390-2411 (2006).
37. Goldstein JA, Demetriou D, Grines CL, Pica M, Shoukfeh M, O'Neill WW: Multiple complex coronary plaques in patients with acute myocardial infarction. N. Engl. J. Med. 343, 915-922 (2000).
38. Lee SG, Lee CW, Hong MK, Kim JJ, Park SW. Park SJ: Change of multiple complex coronary plaques in patients with acute myocardial infarction: a study with coronary angiography. Am. Heart J. 147, 281-286 (2004).
39. Yamagishi M, Terashima M, Awano K et al.: Morphology of vulnerable coronary plaque: insights from follow-up of patients examined by intravascular ultrasound before an acute coronary syndrome. J. Am. Coll. Cardiol. 35, 106-111 (2000).
40. Nair A, Kuban B, Tuzcu M, Schoenhagen-P, Nissen S, Vince G: Coronary plaque classification with intravascular ultrasound radiofrequency data analysis. Circulation 106, 2200-2206 (2002).
41. Sano K, Kawasaki M, Ishihara Y et al. Assessment of vulnerable plaques causing acute coronary syndrome using integrated backscatter intravascular ultrasound. J. Am. Coll. Cardiol. 47, 734-741 (2006).
42. Stamper D, Weissman N, Brezinski M: Plaque characterization with optical coherence tomography. J. Am. Coll. Cardiol. 47, C69-C79 (2006).
43. Brezinski M, Tearney G, Weissman N, Boppart SA, Bouma BE, Hee MR: Assessing atherosclerotic plaque morphology: comparison of optical coherence tomography and high frequency intravascular ultrasound. Heart 77, 397-404 (1997).
44. Patwari P, Weissman N, Boppart S, Jesser C, Stamper D, Fujimoto JG: Assessment of coronary plaque with optical coherence tomography and high frequency ultrasound. Am. J. Cardiol. 85, 641-644 (2000).
45. Caplan J, Waxman S, Nesto R, Mullet J: Near-infrared spectroscopy for the detection of vulnerable coronary artery plaques. J. Am. Coll. Cardiol. 47, C92-C96 (2006).
46. Schaar J, van der Steen A, Mastik F, Baldewsing R, Serruys P: Intravascular palpography for vulnerable plaque assessment. J. Am. Coll. Cardiol. 47, C86-C91 (2006).
47. Madjid M, Willerson J, Casscells W: Intracoronary thermography for detection of high-risk vulnerable plaques. J. Am. Coll. Cardiol. 47, C80-C85 (2006).
48. Uchida Y, Nakamura F, Tomaru T, Morita T, Oshima T, Sasaki T: Prediction of acute coronary syndromes by percutaneous coronary angioscopy in patients with stable angina. Am. Heart J. 130, 195-203 (1995).
49. Redberg RF, Vogel RA, Criqui MH, Herrington DM, Lima JA, Roman MJ: 34th Bethesda Conference: Task force #3: what is the spectrum of current and emerging techniques for the non-invasive measurement of atherosclerosis? J. Am. Coll. Cardiol. 41, 1886-1898 (2003).
50. Cordeiro M, Lima J: Atherosclerotic plaque characterization by multicletector row computed tomography angiography. J. Am. Coll. Cardiol. 47, C40-C47 (2006).
51. Hendel RC, Patel MR, Kramer CM et al.: ACCF/ACR/SCCT/SCMR/ASNC/ NASCI/SCAYSIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American College of Radiology, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance; American Society of Nuclear Cardiology, North American Society for Cardiac Imaging, Society for Cardiovascular Angiography and Interventions, and Society of Interventional Radiology. J. Am. Coll. Cardiol. 48(7), 1475-1497 (2006).
52. Hamon M, Biondi-Zoccai G, Malagutti P et al.: Diagnostic performance of multislice spiral computed tomography of coronary arteries as compared with conventional invasive coronary angiography: a meta-analysis. J. Am. Coll. Cardiol. 48, 1896-1910 (2006).
53. Stein PD, Yaekoub AY, Matta F, Sostman HD: 64-slice CT for diagnosis of coronary artery disease: a systematic review. Am. J. Med. 121, 715-725 (2008).
54. Stein PD, Beemath A, Kayali F et al.: Multidetector CT for the diagnosis of coronary artery disease: a systematic eview. Am. J. Med. 119, 203-216 (2006).
55. Husmann L, Valenta I, Gaemperli O et al.: Feasibility of low-dose coronary CT angiography: first experience with prospective ECC-gacing. Eur. Heart J. 29(2), 191-197 (2008).
56. Husmann L, Valenta I, Kaufmann PA: Coronary angiography with low-dose computed tomography at 1.4 mSv. Herz 33(1), 75 (2008).
57. Hoff J, Chomka E, Kranik A, Daviglus M, Rich S, Kondos GT: Age and gender distributions of coronary artery calcium detected by electron-beam-tomography in 35246 adults. Am. J. Cardiol. 87, 1335-1339 (2001).
58. Schmermund A, Ethel R, Silber S: Age and gender distribution of coronary artery calcium measured by four-slice computed tomography in 2030 persons with no symptoms of coronary artery disease. Am. J. Cardiol. 90, 168-173 (2002).
59. Fuster V, Fayad Z, Moreno P, Poon M, Corti R, Badimon J: Atherothrombosis and high-risk plaque. Part II: approaches by non-invasive computed tomographic/magnetic resonance imaging. J. Am. Coll. Cardiol. 46, 1209-1218 (2005).
60. Detrano R, Guerci A, Carr J et al.: Coronary calcium as a predictor of coronary events in four racia or ethnic groups. N. Engl. J. Med. 358, 1336-1345 (2008).
61. Achcnbach S, Ropers D, Hoffmann U, MacNeill B, Baum U, Pohle K: Assessment of coronary remodeling in stenotic and non-stenotic coronary atherosclerosis lesions by multidetector spiral computed tomography. J. Am. Coll. Cardiol. 43, 842-847 (2004).
62. Leber A, Knez A, Becker A, Becker C, von Ziegler F, Nikolaou K: Accuracy of multidetector spiral computed tomography in identifying and differentiating the composition of coronary atherosclerotic plaques: a comparative study with intracoronary ultrasound. J. Am. Coll. Cardiol. 43, 1241-1247 (2004).
63. Schroeder S, Kopp A, Baumbach A, Meisner C, Kuertner A, Georg C: Noninvasive detection and evaluation of atherosclerotic coronary plaques with multislice computed tomography. J. Am. Coll. Cardiol. 37, 1430-1435 (2001).
64. Wilensky R, Song H, Ferrari V: Role of magnetic resonance and intravascular magnetic resonance in the detection of vulnerable plaques. J. Am. Coll. Cardiol. 47, C48-C56 (2006).
65. Raggi, P, Davidson M, Callister T et al.: Aggressive versus moderate lipid lowering therapy in hypercholesterolemic postmenopausal women: Beyond Endorsed Lipid Lowering with EBT Scanning (BELLES). Circulation 112, 563-571 (2005).
66. Terry JG, Carr JJ, Couba EO, Davis DH, Menon L, Bender K: Effect of simvastatin. (80 mg) on coronary and abdominal aortic arterial calcium (from the coronary artery calcification treatment with zocor [CATZ] study). Am. J. Cardiol. 99, 1714-1717 (2007).
67. Nicholls SJ, Tuzcu EM, Wolski. K, Sipahi I, Schoenhagen P, Crowe T: Coronary artery calcification and changes in atheroma burden in response to established medical therapies. J. Am. Coll. Cardiol. 49, 263-270 (2007).
68. Kampschulre A, Ferguson MS, Kerwin WS, Polissar NL, Chu B, Saam T: Differentiation of intraplaque versus juxtaluminal hemorrhage/thrombus in advanced human carotid atherosclerotic lesions by in vivo magnetic resonance imaging. Circulation 110, 3239-3244 (2004).
69. Cai J, Harsukami TS, Ferguson MS, Kerwin WS, Saam T, Chii B: In vivo quantitative measurement of intact fibrous cap and lipid-rich necrotic core size inatherosclerotic carotid plaque: comparison of high resolution, contrast-enhanced magnetic resonance imaging and histology. Circulation 112, 3437-3444 (2005).
70. Corti R, Fayad ZA, Fuster V, Worthley SG, Helft G, Chesebro J: Effects of lipid-lowering by simvastatin on human atherosclerotic lesions: a longitudinal study by high-resolution, noninvasive magnetic resonance imaging. Circulation 104, 249-252 (2001).
71. Lorenz MW, Markus HS, Bors ML, Rosvall M, Sitzer M: Prediction of clinical cardiovascular events with carotid intima-mediathickness: a systematic review and meta-analysis. Circulation 115, 459-467 (2007).
72. Stein J, Korcarz C, Hurst T et al.: ASE consensus statement: use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine. J. Am. Soc. Echocardiogr. 21(2), 93-109 (2008).
73. Bots ML, Hofinan A, Grobbee DE: Increased common carotid intima media thickness: adaptive response or a reflection of atherosclerosis? Findings from the Rotterdam study. Stroke 28, 2442-2447 (1997).
74. Vaudo G, Schillaci G, Evangelista F, Pasqualini L, Verdecchia P, Mannarino E: Arterial wall thickening at different sites and its association with left ventricular hypertrophy in newly diagnosed essential hypertension. Am. J. Hypertens. 13, 324-331 (2000).
75. Nagai Y, Metter EJ, Earley CJ et al. Increased - carotid artery intimal-medial thickness in asymptornatic older subjects with exercise-induced myocardial ischemia. Circulation 98, 1504-1509 (1998).
76. Kastelein JJ, van Leuven SI, Burgess L, Evans GW, Kuivenhoven JA, Barter PJ: Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia. N. Engl. J. Med. 356, 1620-1630 (2007).
77. Crouse JR 3rd, Raichlen JS, Riley WA, Evans GW Palmer MK, O'Leary DH: Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial. JAMA 297, 1344-1353 (2007).
78. Blankenhorn DH, Selzer RH, Crawford DW, Barth JD, Liu CR, Liu CH: Beneficial effects of colestipol-niacin therapy on the common carotid artery. Two- alid four-year reduction of intima-media thickness measured by ultrasound. Circulation 88, 20-28 (1993).
79. MacMahon S, Sharpe N, Gamble G, Hart H, Scott J, Simes J: Effects of lowering average of below-average cholesterol levels on the progression of carotid atherosclerosis: results of the LIPID Atherosclerosis Substudy. LIPID Trial Research Group. Circulation 97, 1784-1790 (1998).
80. de Groot E, Jukema JW van Boven AJ, Reiber JH, Zwinderman AH, Lie KI: Effect of pravastatin on progression and regression of coronary atherosclerosis and vessel wall changes in carotid and femoral arteries: a report from the Regression Growth Evaluation Statin Study. Am. J. Cardiol. 76, 40C-46C (1995).
81. Crouse JR 3rd, Byington RP, Bond MG, Espeland MA, Craven TE, Sprinkle JW: Pravastarin, lipids, and atherosclerosis in the carotid arteries (PLAC-II). Am. J. Cardiol. 75, 455-459 (1995).
82. Espeland MA, O'Leary DH, Terry JG, Morgan T, Evans G, Mudra H: Carotid intimal-media thickness as a surrogate for cardiovascular disease events in trials of HMG-CoA reductase inhibitors. Curr. Control. Trials Cardiovaic. Med. 6, 3 (2005).
83. Hodis H, Mack W, LaBree L et al.: The role of carotid arterial intima-medial thickness in predicting clinical coronary events. Ann. Intern. Med. 128, 262-269 (1998).
84. Jaffer FA, Libby P, Weissleder R: Molecular imaging of cardiovascular disease. Circulation 116, 1052-1061 (2007).
85. 18F] -fluorodeoxyglucose positron emission tomography. Circulation 105, 2708-2711 (2002).
86. 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J. Am. Coll. Cardiol. 48, 1818-1824 (2006).
87. Tahara N, Kai H, Ishibashi M, Nakaura H, Kaida H, Baba K: Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucosc positron emission tomography. J. Am. Coll. Cardiol. 48, 1825-1831 (2006).
88. 18F-fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials. J. Am. Coll. Cardiol. 50, 892-896 (2007).
89. Kooi ME, Cappendijk VC, Cleutjens KB et al.: Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging. Circulation 107, 2453-2458 (2003).
90. Trivedi RA, Mallawarachi C, U-King-Im JM et al.: Identifying inflamed carotid plaques using in vivo USPIO-enhanced MR imaging to label plaque macrophages. Arterioscler. Thromb. Vasc. Biol. 26, 1601-1606 (2006).
91. Trivedi RA, U-King-Im JM, Graves MJ, Kirkpatrick PJ, Gillard JH: Noninvasive imaging of carotid plaque inflammation. Neurology 63, 187-188 (2004).
92. Trivedi RA, U-King-Im JM, Graves MJ et al.: In vivo detection of macrophages in human carotid atheroma: temporal dependence of ultrasmall superparamagnetic particles of iron oxide-enhanced MRI. Stroke 35, 1631-1635 (2004).
93. Tang T, Howarth SP, Miller SR et al.: Assessment of inflammatory burden contralateral to the symptomatic carotid scenosis using high-resolution ultrasmall, superparamagnetic iron oxide-enhanced MRI. Stroke 37, 2266-2270 (2006).
94. Amirbekian V, Lipinski M, Briley-Saebo K et al.: Detecting and assessing macrophages in vivo to evaluate atherosclerosis noninvasively using molecular MRI. Proc. Natl Acad. Sci. USA 104, 961-966 (2007).